Nanofiber Dressing With Silver Speeds Wound Closure

Electrospun PVA/PVP mats loaded with silver nanoparticles and nitrofurazone showed antibacterial activity and wound-healing effects in rabbit tests.

Updated on Nov. 14, 2026 in Materials Science

Translucent white nanofibrous mat draped over a metal drum in a laboratory, with fine silvery fibers catching soft daylight.
Researchers in a 12-day rabbit study found a silver-loaded nanofiber dressing closed wounds about 90 percent, with antibacterial activity. AI Illustration. Upload story photo >

Researchers fabricated nanofibrous mats from PVA and PVP blended with silver nanoparticles and nitrofurazone by electrospinning. In rabbit testing, the formulation with 1.5 wt% silver nanoparticles achieved approximately 90% wound closure after 12 days.

Why it matters

The mats combined antibacterial activity with cell compatibility, with cell viability staying above 78% in lab tests, though viability fell as silver content rose. The findings suggest a route to wound dressings that address infection and healing together.

Antibacterial inhibition zones measured 6.3 to 10.7 mm for all silver-containing mats, while the nitrofurazone-only mat inhibited only Staphylococcus aureus at 6.3 mm. Long-term safety and performance in human wounds remain untested.

The players

New Zealand White rabbits

A common laboratory rabbit breed widely used in preclinical wound-healing and dermatology research.

The details

The team synthesized silver nanoparticles in situ by hydrothermal reduction of silver nitrate within a PVA solution, then electrospun the blend with PVP and nitrofurazone into nanofibrous mats. Silver loadings of 0.4, 0.75, and 1.5 wt% were compared across fiber mats tested for cytotoxicity, antibacterial effect, and wound healing in New Zealand White rabbits.

Timeline

  1. The wound-closure measurement window in the rabbit study was 12 days.

The Big Picture

Electrospun nanofiber dressings have been developed as a route to delivering antimicrobial agents directly into wound beds. This work extends that line of research by pairing silver nanoparticles with a second antibiotic-like agent in the same PVA/PVP matrix.

Dressings built on this approach could eventually combine infection control with faster healing in a single material. Commercialization timelines and human clinical testing have not been reported.

The takeaway

Materials that release antibacterial agents while supporting cell growth are a key goal in wound care research. Results so far come from laboratory and animal studies, and human trials will be needed before any clinical use.

Further reading

Explore more materials science research on engineered fibers and biomaterials.

Source note: This article includes information reported by Nature.